Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
NCT01949129Phase 3Recruiting
- Sponsor
- St. Anna Children's Cancer Research Institute
- Start
- Apr 2013
- Primary completion
- Jun 2030
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 31
01
Overview
A Phase 3 trial of fludarabine, thiotepa, treosulfan, busulfan in acute lymphoblastic leukemia (ALL), sponsored by St. Anna Children's Cancer Research Institute. Started Apr 2013; status: recruiting.
02
Drugs
fludarabinethiotepatreosulfanbusulfan
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01949129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01949129.